Bausch Health Companies (BHC) Change in Account Payables (2009 - 2012)
Bausch Health Companies' (BHC) quarterly Change in Account Payables came in at -$9.9 million in Q1 2012, up 73.76% year-over-year from -$5.7 million in Q2 2011, and up 35.91% quarter-over-quarter from -$15.5 million in Q4 2011.
Analysis
Bausch Health Companies (BHC) Change in Account Payables (2009 - 2012) Analysis & Trends
Bausch Health Companies has disclosed Change in Account Payables across 4 years of filings, most recently posting -$9.9 million for Q1 2012.
- In Q1 2012, Change in Account Payables rose 73.76% year-over-year to -$9.9 million; the TTM figure through Mar 2012 stood at $18.9 million (up 122.46% YoY), while the FY2011 annual figure was -$9.0 million, up 88.2% from the prior year.
- Change in Account Payables came in at -$9.9 million for Q1 2012 at Bausch Health Companies, up from -$15.5 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $34.1 million in Q4 2009 to a low of -$68.1 million in Q4 2010.
- Average Change in Account Payables over 4 years is -$4.0 million, with a median of $2.8 million recorded in 2009.
- Year-over-year, Change in Account Payables tumbled 299.6% in 2010 and surged 4958.13% in 2011.
- Over 4 years, Change in Account Payables stood at $34.1 million in 2009, then plunged by 299.6% to -$68.1 million in 2010, then soared by 77.26% to -$15.5 million in 2011, then soared by 35.91% to -$9.9 million in 2012.
- Per Business Quant data, the three most recent Change in Account Payables figures were -$9.9 million in Q1 2012, -$15.5 million in Q4 2011, and $16.8 million in Q3 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -21.20 Mn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 45.25 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | -8.53 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 30.70 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | -1.12 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2012 | -9.92 Mn |
| Dec 31, 2011 | -15.48 Mn |
| Sep 30, 2011 | 16.81 Mn |
| Jun 30, 2011 | 27.50 Mn |
| Mar 31, 2011 | -37.81 Mn |
| Dec 31, 2010 | -68.08 Mn |
| Sep 30, 2010 | 22.28 Mn |
| Jun 30, 2010 | -566,000.00 |
| Mar 31, 2010 | -29.73 Mn |
| Dec 31, 2009 | 34.11 Mn |
| Sep 30, 2009 | 6.77 Mn |
| Jun 30, 2009 | 6.22 Mn |